Pedrani, M.; Salfi, G.; Merler, S.; Testi, I.; Agrippina Clerici, C.M.; Pecoraro, G.; Castelo-Branco, L.; Turco, F.; Tortola, L.; Vogl, U.;
et al. Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. Int. J. Mol. Sci. 2025, 26, 5309.
https://doi.org/10.3390/ijms26115309
AMA Style
Pedrani M, Salfi G, Merler S, Testi I, Agrippina Clerici CM, Pecoraro G, Castelo-Branco L, Turco F, Tortola L, Vogl U,
et al. Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. International Journal of Molecular Sciences. 2025; 26(11):5309.
https://doi.org/10.3390/ijms26115309
Chicago/Turabian Style
Pedrani, Martino, Giuseppe Salfi, Sara Merler, Irene Testi, Chiara Maria Agrippina Clerici, Giovanna Pecoraro, Luis Castelo-Branco, Fabio Turco, Luigi Tortola, Ursula Vogl,
and et al. 2025. "Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting" International Journal of Molecular Sciences 26, no. 11: 5309.
https://doi.org/10.3390/ijms26115309
APA Style
Pedrani, M., Salfi, G., Merler, S., Testi, I., Agrippina Clerici, C. M., Pecoraro, G., Castelo-Branco, L., Turco, F., Tortola, L., Vogl, U., Gillessen, S., Theurillat, J.-P., Zilli, T., & Mestre, R. P.
(2025). Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. International Journal of Molecular Sciences, 26(11), 5309.
https://doi.org/10.3390/ijms26115309
